Our mission is to improve glaucoma surgery through patient-specific pressure control. Reduce failures and post-operative complications.
Who we are
Rheon Medical is founded in 2010 as a spin-off from the Swiss Federal Institute of Technology, Lausanne (EPFL). The eyeWatch technology was based on many years of front-line research on non invasively-controlled implantable microfluidic devices. The technology was further refined and validated in the preclinical and clinical setting. Rheon’s management has more than 100 years of combined experience in the development and commercialisation of medical technologies. We are backed by a board with high-caliber executives in the ophthalmology field.
Our vision is to become a leading company in the surgical treatment of glaucoma. We strive to provide glaucoma patients with the technology to make glaucoma surgery the safest and most efficacious procedure.